Markers of bladder cancer. State of the art

H. Barton Grossman; Colin P.N. Dinney

doi:10.1016/S1078-1439(99)00002-2

Markers of bladder cancer. State of the art

H. Barton Grossman, Colin P.N. Dinney

Urology

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Abstract

Biomarkers are increasingly being applied to the clinical management of patients with bladder cancer. The biomarkers in current clinical use focus on bladder cancer detection. Biomarkers for prognosis and as intermediate endpoints for chemoprevention are being evaluated in clinical trials. This review provides an overview of the performance characteristics of current clinical markers and other markers that are currently under evaluation. Copyright (C) 2000 Elsevier Science Inc.

Original language	English (US)
Pages (from-to)	3-10
Number of pages	8
Journal	Urologic Oncology
Volume	5
Issue number	1
DOIs	https://doi.org/10.1016/S1078-1439(99)00002-2
State	Published - Jan 2000

Keywords

Biomarkers
Bladder cancer
Detection
Prognosis

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/S1078-1439(99)00002-2

Cite this

@article{691af55bc9064a179b00f98cb65efac1,

title = "Markers of bladder cancer. State of the art",

abstract = "Biomarkers are increasingly being applied to the clinical management of patients with bladder cancer. The biomarkers in current clinical use focus on bladder cancer detection. Biomarkers for prognosis and as intermediate endpoints for chemoprevention are being evaluated in clinical trials. This review provides an overview of the performance characteristics of current clinical markers and other markers that are currently under evaluation. Copyright (C) 2000 Elsevier Science Inc.",

keywords = "Biomarkers, Bladder cancer, Detection, Prognosis",

author = "Grossman, {H. Barton} and Dinney, {Colin P.N.}",

note = "Funding Information: This article was supported in part by grant number CA56973 from the National Cancer Institute. ",

year = "2000",

month = jan,

doi = "10.1016/S1078-1439(99)00002-2",

language = "English (US)",

volume = "5",

pages = "3--10",

journal = "Urologic Oncology",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Markers of bladder cancer. State of the art

AU - Grossman, H. Barton

AU - Dinney, Colin P.N.

N1 - Funding Information: This article was supported in part by grant number CA56973 from the National Cancer Institute.

PY - 2000/1

Y1 - 2000/1

N2 - Biomarkers are increasingly being applied to the clinical management of patients with bladder cancer. The biomarkers in current clinical use focus on bladder cancer detection. Biomarkers for prognosis and as intermediate endpoints for chemoprevention are being evaluated in clinical trials. This review provides an overview of the performance characteristics of current clinical markers and other markers that are currently under evaluation. Copyright (C) 2000 Elsevier Science Inc.

AB - Biomarkers are increasingly being applied to the clinical management of patients with bladder cancer. The biomarkers in current clinical use focus on bladder cancer detection. Biomarkers for prognosis and as intermediate endpoints for chemoprevention are being evaluated in clinical trials. This review provides an overview of the performance characteristics of current clinical markers and other markers that are currently under evaluation. Copyright (C) 2000 Elsevier Science Inc.

KW - Biomarkers

KW - Bladder cancer

KW - Detection

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0033992577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033992577&partnerID=8YFLogxK

U2 - 10.1016/S1078-1439(99)00002-2

DO - 10.1016/S1078-1439(99)00002-2

M3 - Review article

C2 - 21227279

AN - SCOPUS:0033992577

SN - 1078-1439

VL - 5

SP - 3

EP - 10

JO - Urologic Oncology

JF - Urologic Oncology

IS - 1

ER -

Markers of bladder cancer. State of the art

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this